Eh. Nah et al., CD4 AND CD8 ANTIGEN COEXPRESSION - A FLOW CYTOMETRIC STUDY OF PERIPHERAL-BLOOD, BONE-MARROW, BODY-FLUID, AND SOLID LYMPHORETICULAR SPECIMENS, Archives of pathology and laboratory medicine, 121(4), 1997, pp. 381-384
Citations number
17
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
Objective.-CD4 and CD8 antigen coexpression occurs not only on blastic
T-cell malignancies, but also on a small subset of mature lymphocytes
. The aim of this study was to determine the prevalence of this popula
tion of cells and to identify features that can be used to differentia
te them from T lymphoblasts. Design.-All specimens submitted to the cl
inical flow cytometry laboratory from August 1, 1994, through July 31,
1995, were analyzed for CD4 and CD8 coexpression. Main Outcome Measur
e.-Percentage of lymphocytes coexpressing the CD4 and CD8 antigens. Re
sults.-Four percent (22/526) of all specimens contained a population o
f CD4/CD8 coexpressing cells. Five cases represented CD4 and CD8 antig
en expression on neoplastic cells. In 17 cases, the CD4/CD8 coexpressi
ng cells appeared to represent a population of mature lymphocytes with
a normal phenotype. The immature cells of T-cell acute lymphocytic le
ukemia and lymphoblastic lymphoma represented a dominant uniform popul
ation of cells demonstrating strong staining with both the CD4 and CD8
antigens. Cases containing a mature population of CD4/CD8 coexpressin
g cells were characterized by fewer coexpressing cells and variable ex
pression of CD8. There were cases where distinction of this population
of mature CD4/CD8 coexpressing lymphoid cells from a blastic malignan
cy was not possible using immunophenotyping alone. Conclusion.-Correla
tion of clinical, morphologic, and immunophenotypic data is recommende
d to prevent the misdiagnosis of subtle involvement by a blastic T-cel
l malignancy.